Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response

Infection and Immunity

Volumn 69, Issue 8, 2001, Pages 4906-4915

  Kebaier C ^a   Louzir, H ^a   Chenik, M ^a   Ben Salah, A ^a   Dellagi, K ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE SEQUENCE; IMMUNE RESPONSE; INOCULATION; LEISHMANIA MAJOR; MIDDLE EAST; MONONUCLEAR CELL; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; TUNISIA; ZOONOSIS;

ADULT; ANIMALS; ANTIGENS, PROTOZOAN; BONE MARROW CELLS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENETIC HETEROGENEITY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 0034918999     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.8.4906-4915.2001     Document Type: Article

References (56)

1. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice
2. Isolation of lmcpc, a gene encoding a Leishmania mexicana cathepsin-B-like cysteine proteinase
3. A randomized placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment
4. Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania
5. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: A possible role of virulence molecules (gp63 and LPG)
6. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites
7. Metacyclogenesis is a major determinant of Leishmania promastigotes virulence and attenuation
8. Glycoconjugates in Leishmania infectivity
9. Single gene control of resistance to cutaneous leishmaniasis in mice
10. Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major
11. Genomic organization and expression of a differentially-regulated gene family from Leishmania major
12. Effects of promastigote growth phase, frequency of subculture and host age on promastigote initiated infections with Leishmania donovani in the golden hamster
13. Use of recombinant DNA probes for species identification of Old World Leishmania isolates
14. Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for the expansion of distinct helper T cell subsets
15. Immunological regulation of cutaneous experimental leishmaniasis. I. Immunogenetic aspects of susceptibility to Leishmania tropica in mice
16. Leishmania major Hsp 100 is required chiefly in the mammalian stage of the parasite
17. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana
18. Proteophosphoglycans from Leishmania promastigotes and amastigotes
19. Resistance to Leishmania major induced by tolerance to a single antigen
20. A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan
21. Dissemination in cutaneous leishmaniasis. II. Satellite papules and subcutaneous induration
22. Setting in motion the immune mehanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major
23. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice
24. -
25. Leishmania major. A clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone
26. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
27. Helper T-cell subsets in mouse leishmaniasis: Induction, expansion and effector function
28. Immunological determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major
29. Diversity in repeat-containing surface proteins of Leishmania major
30. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes
31. Profile of human T cell response to leishmanial antigens: Analysis by immunoblotting
32. Designing glycoconjugate biosynthesis for an insidious intent: Phosphoglycan assembly in Leishmania parasites
33. The multiple cpb cysteine proteinase genes of Leishmania mexicana encode isoenzymes, which differ in their stage regulation and substrate preferences
34. Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulent factors
35. Expression cloning of a protective Leishmania antigen
36. Reduced expression of lipophosphoglycan and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture
37. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins
38. Metacyclogenesis in Leishmania promastigotes
39. Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis
40. The generation of infective stage Leishmania major promastigotes is associated with the cell surface expression and release of a developmentally regulated glycolipid
41. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes
42. Identification of an infective stage of Leishmania promastigotes
43. A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva
44. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes
45. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens
46. Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan
47. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major
48. Development of a safe live Leishmania vaccine line by gene replacement
49. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice
50. Salivary gland lysates of the sandfly Lutzomyia longipalpis enhance Leishmania infectivity
51. The lipophosphoglycan Leishmania parasites
52. Heat-shock genes: Regulatory role for differentiation in parasitic protozoa
53. The effect of BCG on experimental cutaneous leishmaniasis in mice
54. Control of the leishmaniasis
55. In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani. L. major and L. mexicana
56. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2